Clinical Trial Update: Intrapartum Sildenafil Citrate to Prevent Non Reassuring Foetal Status Among Parturients Delivering at Term [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intrapartum sildenafil citrate to prevent non-reassuring fetal status in term deliveries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Foetal Hypoxia

Drugs mentioned

• Sildenafil citrate (Sildenafil citrate)

Snippet

Sponsor: Ladoke Akintola University of Technology Teaching Hospital, Ogbomoso | Conditions: Foetal Hypoxia | Phase 4 | Status: UNKNOWN